Stock Taper 
LNAI
$2.37
▲ UP 0.85% (0.02)
KEY STATISTICS
Market Cap$10.75 M
52w High$19.60
52w Low$1.21
Dividend Yield—
Frequency—
P/E-3.21
Volume35.20K
Shares Out.4.53M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
David H. Weinstein
ABOUT
SECTOR
Healthcare
WENT PUBLIC
September 30, 2025
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
29
UPCOMING EARNINGS
DateSep 28, 2026
DayMonday
Rev. Est.—
SEP
28
MON
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2026-05-22 | Reverse | 1:8 |
PRICE
$2.37 ▲ UP 0.85% (+$0.02)About Lunai Bioworks Inc.
https://www.lunaibioworks.com ↗A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.
INDUSTRY
Biotechnology
A SERVICE LUNAI BIOWORKS INC. IS KNOWN FOR
AI-Powered Drug Discovery and Biodefense Platform
An AI platform that integrates biomedical data to accelerate therapeutics and biodefense, recently featured on CNBC and protected by a U.S. patent for its data analysis architecture.
ETFS HOLDING THIS STOCK
ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
RATINGS SNAPSHOT
Overall rating: C
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 ANL | $13.82 | COMPARE |
 APLM | $26.60 | COMPARE |
 LPCN | $2.17 | COMPARE |
 BLRX | $2.60 | COMPARE |
 ICU | $3.09 | COMPARE |
 GOVX | $0.72 | COMPARE |
 MBRX | $0.65 | COMPARE |
 ERNA | $4.57 | COMPARE |